Cart
sales@molnova.com
N-Vanillyldecanamide
CAS No. 31078-36-1
N-Vanillyldecanamide( Decylic acid vanillylamide )
Catalog No. M24240 CAS No. 31078-36-1
N-Vanillyldecanamide is a capsaicinoid isolated from the fruits of Capsicum annuum. It significantly reduced the radical length of Lactuca sativa seedling in a dose-dependent manner.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 67 | In Stock |
|
| 2MG | 35 | In Stock |
|
| 5MG | 56 | In Stock |
|
| 10MG | 93 | In Stock |
|
| 25MG | 155 | In Stock |
|
| 50MG | 221 | In Stock |
|
| 100MG | 328 | In Stock |
|
| 200MG | 458 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameN-Vanillyldecanamide
-
NoteResearch use only, not for human use.
-
Brief DescriptionN-Vanillyldecanamide is a capsaicinoid isolated from the fruits of Capsicum annuum. It significantly reduced the radical length of Lactuca sativa seedling in a dose-dependent manner.
-
DescriptionN-Vanillyldecanamide is a capsaicinoid isolated from the fruits of Capsicum annuum. It significantly reduced the radical length of Lactuca sativa seedling in a dose-dependent manner.
-
In Vitro——
-
In Vivo——
-
SynonymsDecylic acid vanillylamide
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number31078-36-1
-
Formula Weight307.43
-
Molecular FormulaC18H29NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO:250 mg/mL (813.19 mM; Need ultrasonic)
-
SMILESCCCCCCCCCC(NCC1=CC=C(O)C(OC)=C1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
MBP (68-82), guinea ...
Myelin Basic Protein (68-82), guinea pig, is a peptide with the sequence Tyr-Gly-Ser-Leu-Pro-Gln-Lys-Ser-Gln-Arg-Ser-Gln-Asp-Glu-Asn.Myelin Basic Protein (MBP) (68-82), guinea pig is a fragment of myelin basic protein (MBP).
-
BAY 2416964
BAY 2416964 is a potent and orally active aryl hydrocarbon receptor (AHR) antagonist extracted from patent WO2018146010A1 (example 192, IC50: 341 nM). It has the potential for cancer treatment.BAY 2416964 induces AHR-regulated gene CYP1A1 expression in human monocytic U937 cells (IC50: 4.3 nM).
-
Isonicotinamide
Pharmaceutical intermediate used to synthesis Cefalonium, etc.
